思创医惠控制权变更，苍南芯盛将成公司控股股东

Core Viewpoint - The company is undergoing a significant change in control, with Cangnan Xincheng acquiring shares and voting rights to become the actual controller, shifting from no actual controller to Wei Naixu as the new controlling party [1][3]. Group 1: Share Transfer and Voting Rights - Cangnan Xincheng will acquire 62.7395 million shares from the largest shareholder, Lu Nan, representing 5.61% of the total share capital [1]. - Following the transfer, Lu Nan's direct shareholding will decrease from 62.7395 million shares to 0, while indirect holdings through Hangzhou Botai Investment Management will drop from 6.15% to 0.54% [1]. - A voting rights entrustment agreement has been signed, allowing Cangnan Xincheng to exercise rights over 63.8902 million shares held by Sijia Wulian, which is 5.72% of the total [2]. Group 2: Control and Management Changes - After the completion of the share transfer and voting rights entrustment, Cangnan Xincheng will directly hold 62.7395 million shares, while Wei Naixu will indirectly hold a total of 83.4719 million shares, equating to 7.47% of the total share capital [3]. - The total voting rights held will amount to 147 million shares, or 13.18% of the total [3]. - The company will transition from having no actual controller to being controlled by Wei Naixu, who is recognized for his expertise in the IoT sector and is expected to enhance the company's competitiveness and growth [3]. Group 3: Previous Share Transfer Attempts - A previous agreement was made for Lu Nan to transfer the same number of shares to Cangnan Industrial Construction Investment, which would have resulted in a combined holding of 11.33% with Sijia Wulian [4]. - This earlier transfer was terminated following a notice from the Zhejiang Provincial State-owned Assets Supervision and Administration Commission, indicating regulatory challenges [4].